|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.46 USD | +1.81% |
|
+4.05% | +8.85% |
| 02/07 | Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc. Appoints Patricia Drake as Chief Commercial Officer | CI |
| 18/06 | Cantor Fitzgerald Initiates Innoviva at Overweight Rating | MT |
Effective January 11, 2016, Theravance Inc. will change its Nasdaq Global Select stock ticker symbol to INVA from THRX.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.85% | 1.09B | |
| +55.35% | 815B | |
| +31.99% | 597B | |
| -0.10% | 377B | |
| +15.47% | 319B | |
| +13.10% | 310B | |
| +12.84% | 250B | |
| +16.32% | 247B | |
| +16.54% | 180B | |
| +4.31% | 170B |
INNOVIVA, INC. 
